Salesforce executive sells over $1.5m in company stock

Salesforce, Inc. (NYSE:CRM) President and COO Brian Millham has recently engaged in significant trading activity involving the company's common stock, according to a new SEC filing. Millham completed a series of sales totaling over $1.5 million, with individual sale prices ranging from approximately $264.78 to $267.75 per share.

On September 23, Millham sold 821 shares at a price of $264.7813 per share, followed by another sale of 858 shares at the same price, resulting in a total sale value of $444,567 for these transactions. Additionally, the executive sold 863 shares at a weighted average price of $265.3604, with sales prices ranging from $264.99 to $265.72. He also sold 2,996 shares at a weighted average price of $267.1749, with transaction prices between $266.37 and $267.25, and 197 shares at an average price of $267.7503, with prices varying from $267.73 to $267.77. The total value of these sales amounted to $1,082,208.

Besides the stock sales, Millham also exercised options to acquire Salesforce shares. He exercised options for 2,038 shares at a price of $186.51 and another 2,018 shares at $215.17, which amounted to a total acquisition value of $814,320.

It is worth noting that some of the sales were made to satisfy the tax withholding obligations related to the vesting of restricted stock units. Moreover, the transactions were executed automatically under a Rule 10b5-1 trading plan that Millham had adopted on December 22, 2023, which allows insiders to set up a predetermined plan to sell stocks at a time when they are not in possession of material non-public information.

The transactions come as part of the regular financial activity of corporate executives, who often buy and sell shares of their own companies for various personal financial reasons. Investors tend to keep an eye on insider trading for insights into executive confidence in the company's prospects, although such transactions do not always provide a clear signal.

Salesforce shares continue to be actively traded on the New York Stock Exchange, with investors and market watchers closely monitoring insider trading patterns for indications of the company's performance and strategic direction.



In other recent news, Salesforce.com (NYSE:CRM ) reported robust second-quarter earnings, with earnings per share reaching $2.56, surpassing the consensus estimate of $2.36. The company also saw an 8% increase in sales, primarily driven by a 9% rise in subscription and support revenues. Salesforce also entered a definitive agreement to acquire Own Company, a provider of data protection and management solutions, for $1.9 billion in cash. The company's strategic focus on AI was showcased at the recent Dreamforce conference with the introduction of Agentforce, an AI-driven suite of autonomous bots, and a partnership with IBM (NYSE:IBM ) to integrate advanced AI capabilities into its platform. Analyst firms such as BofA Securities, TD Cowen, Needham, and Baird have maintained their ratings on Salesforce, while Truist Securities revised its price target for Salesforce to $300, maintaining a Buy rating. However, Erste Group downgraded the stock from Buy to Hold due to projected slower growth. These recent developments underscore Salesforce's commitment to innovation in the AI space and its potential for future growth.
InvestingPro Insights


As Salesforce's President and COO, Brian Millham, engages in notable stock transactions, investors are keen to understand the financial health and market position of the company. According to InvestingPro data, Salesforce boasts a substantial market capitalization of $252.99 billion, reflecting its significant presence in the industry. The company's gross profit margin for the last twelve months as of Q2 2025 stands at an impressive 76.35%, underscoring its ability to maintain profitability. Additionally, Salesforce has demonstrated a revenue growth of 10.26% over the same period, indicating sustained business expansion.

From an investment perspective, Salesforce's P/E ratio is currently 45.46, which aligns with the company's growth trajectory when considering the adjusted P/E ratio for the last twelve months as of Q2 2025 is 41.92. This suggests that the company is trading at a lower multiple relative to its near-term earnings growth, an InvestingPro Tip that highlights the potential value for investors. Moreover, Salesforce's stock has shown low price volatility, providing a degree of stability in an investor's portfolio.

For those seeking further insights and analysis, InvestingPro offers additional tips on Salesforce, including the company's aggressive share buyback strategy and its status as a prominent player in the software industry. There are currently 23 more InvestingPro Tips available for Salesforce, which can be found at https://www.investing.com/pro/CRM, offering a comprehensive look at the company's financial metrics and investment potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com

Последние публикации
Oil firms evacuating US Gulf of Mexico staff as major hurricane looms
24.09.2024 - 07:00
Pro Research: Wall Street eyes Adobe's AI-driven growth
24.09.2024 - 06:00
Pro Research: Wall Street eyes Autodesk amid strategic shifts
24.09.2024 - 06:00
Pro Research: Wall Street dives into Apple's diverse prospects
24.09.2024 - 06:00
Asian stocks rise on China stimulus cheer; Australia lags before RBA
24.09.2024 - 06:00
Salesforce CTO Harris Parker sells shares worth over $249k
24.09.2024 - 05:00
Pro Research: Wall Street deep dive into Nike's market dynamics
24.09.2024 - 05:00
Avidity Biosciences CFO sells over $500k in company stock
24.09.2024 - 05:00
Salesforce executive sells over $1.5m in company stock
24.09.2024 - 05:00
American Eagle Outfitters exec chairman sells over $20 million in stock
24.09.2024 - 05:00
Avidity Biosciences executive sells over $1 million in company stock
24.09.2024 - 05:00
Salesforce executive sells over $17k in company stock
24.09.2024 - 05:00
Avidity Biosciences CEO sells over $1.4 million in company stock
24.09.2024 - 05:00
Salesforce exec Tallapragada sells shares worth over $249k
24.09.2024 - 05:00
Avidity Biosciences executive sells over $578k in stock
24.09.2024 - 05:00

© Analytic DC. All Rights Reserved.

new
Обзор рынка Деловая активность в США в сентябре осталась стабильной, но ценовое давление усиливается
Добро пожаловать в чат поддержки!
*
*

Ваш запрос успешно отправлен!
Скоро с вами свяжутся.